A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells

A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
复制标题

DOI:
10.1016/j.biopha.2020.110390
复制
发表时间:
2020
期刊:
Biomedicine Parmacotherapy
影响因子:
--
通讯作者:
Zhou Hongsheng
Zhou Hongsheng
中科院分区:
--
文献类型:
--
作者:
He Bailin;Wang Qiang;Liu Xiaoli;Lu Ziyuan;Han Jiaochan;Pan Chengyun;Carter Bing Z.;Liu Qifa;Xu Na;Zhou Hongsheng

文献摘要

相似文献